how do i control (monitor) patients receiving trt after ... · how do i control (monitor) patients...
TRANSCRIPT
![Page 1: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/1.jpg)
How do I control (monitor) patients receiving TRT after
prostate cancer treatment
Anthony J. Bella MD, FRCSCGreta and John Hansen Chair in Men’s Health ResearchDivision of Urology, Department of SurgeryUniversity of Ottawa
![Page 2: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/2.jpg)
ACKNOWLEDGEMENTS
Research FundingProstate Cancer Research Foundation of CanadaCanadian Male Sexual Health CouncilCanadian Foundation for Innovation GrantNortheastern Section of the AUAAmerican Medical Systems PROPPER Study (ClinicalTrials.gov Identifier: NCT01383018)Greta and John Hansen Chair in Men’s Health Research
Speakers Bureau/Honoraria/Consulting Fees: Eli Lilly Inc, Pfizer, Abbott, American Medical Systems, Coloplast, Actavis Specialty Pharmaceuticals
![Page 3: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/3.jpg)
![Page 4: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/4.jpg)
![Page 5: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/5.jpg)
![Page 6: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/6.jpg)
[Unit name – Lecture title – Prof name]
![Page 7: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/7.jpg)
![Page 8: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/8.jpg)
POST-RADICAL PROSTATECTOMY TREATMENT WITH TESTOSTERONE
![Page 9: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/9.jpg)
![Page 10: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/10.jpg)
![Page 11: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/11.jpg)
BACKGROUND
![Page 12: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/12.jpg)
White Paper Position Statement
![Page 13: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/13.jpg)
White Paper Position Statement
![Page 14: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/14.jpg)
![Page 15: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/15.jpg)
• PSA velocity (PSAV) was calculated using linear regression of three of more measured serum PSA levels obtained during at least a 12 month period
![Page 16: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/16.jpg)
![Page 17: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/17.jpg)
![Page 18: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/18.jpg)
![Page 19: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/19.jpg)
[Unit name – Lecture title – Prof name]
![Page 20: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/20.jpg)
BRACHYTHERAPY AND TREATMENT WITH TESTOSTERONE
![Page 21: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/21.jpg)
BJU Int. 2014 Jul;114(1):125-30.Long-acting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer.Balbontin FG, Moreno SA, Bley E, Chacon R, Silva A, Morgentaler A.
Serum PSA and testosterone concentrations were recorded monthly for 3 months, then every 3 months for the first year, every 6 months for the second year, and annually then after.
![Page 22: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/22.jpg)
BJU Int. 2014 Jul;114(1):125-30.Long-acting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer.Balbontin FG, Moreno SA, Bley E, Chacon R, Silva A, Morgentaler A.
Serum PSA and testosterone concentrations were recorded monthly for 3 months, then every 3 months for the first year, every 6 months for the second year, and annually then after.
CONCLUSIONS: With a median of 31-months follow-up, long-acting testosterone injections inmen with prostate cancer treated with brachytherapy produced significant clinical benefits. There were no cases of rising serum PSA, prostate cancer progression or recurrence.
![Page 23: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/23.jpg)
ACTIVE SURVEILLANCE AND TREATMENT WITH TESTOSTERONE
![Page 24: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/24.jpg)
![Page 25: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/25.jpg)
CONCLUSIONS
![Page 26: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/26.jpg)
CLINICAL SCENARIO
![Page 27: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/27.jpg)
CLINICAL SCENARIO
• Symptomatic hypogonadism……treat or not treat?
![Page 28: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/28.jpg)
SO HERE WE GO……
• Symptomatic hypogonadism……treat.• How to follow if decide to treat?
![Page 29: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/29.jpg)
• There is no consensus on “careful monitoring” of our patients
• There are no specific differentiators for “vigorous surveillance protocol”
• We use 1,1,1 then 3,3 then 6 month intervals including PSA, measure of T levels, and HCT/HGb
CLINICAL SCENARIO - MONITORING
![Page 30: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/30.jpg)
CLINICAL SCENARIO – FOLLOW-UP
![Page 31: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/31.jpg)
CLINICAL SCENARIO 1 – PREVIOUS ADT
![Page 32: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/32.jpg)
• We use 1,1,1 then 3,3 then 6 month intervals including PSA, measure of T levels, and HCT/HGb
• Post‐RP pts receive TST/TRT if organ confined disease (negative margins, no SV invasion, Gleason less than 8) and undetectable PSA (<0.04)
• PSA rise to over 0.2 triggers oncologic assessment
CONCLUSIONS – POST RP
![Page 33: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/33.jpg)
• For active surveillance, biopsy at 6‐12 months includes anterior directed cores (CCO‐PEBC Guidelines first authored by my colleague Prof. Chris Morash)
• If continues on AS, biospy q3‐5 yrs until age 80• If young age, more than 2 cores, more than 50% any core – q2 yr biopsy
• Multiparametric MRI for discordant findings (PSA increase with no Gleason change or volume on bx) used for “fusion” targeted biopsy
• To come off TST/TRT – increase in Gleason score or concerning rise in PSA (no clear guide here)
CONCLUSIONS – ACTIVE SURVEILLANCE
![Page 34: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/34.jpg)
• For active surveillance, biopsy at 6‐12 months includes anterior directed cores (CCO‐PEBC Guidelines first authored by my colleague Prof. Chris Morash)
• If continues on AS, biospy q3‐5 yrs until age 80• If young age, more than 2 cores, more than 50% any core – q2 yr biopsy
• Multiparametric MRI for discordant findings (PSA increase with no Gleason change or volume on bx) used for “fusion” targeted biopsy
• To come off TST/TRT – increase in Gleason score or concerning rise in PSA (no clear guide here)
CONCLUSIONS – ACTIVE SURVEILLANCE
![Page 35: How do I control (monitor) patients receiving TRT after ... · How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and](https://reader031.vdocument.in/reader031/viewer/2022013023/5fd15b7c22eeca56547c587b/html5/thumbnails/35.jpg)
How do I control (monitor) patients receiving TRT after
prostate cancer treatment
Anthony J. Bella MD, FRCSCGreta and John Hansen Chair in Men’s Health ResearchDivision of Urology, Department of SurgeryUniversity of Ottawa